Nuvo Pharm Company Profile

What is the competitive landscape for NUVO PHARM

NUVO PHARM has twenty approved drugs.

There are four US patents protecting NUVO PHARM drugs.

Summary for Nuvo Pharm

US Patents:	4
Tradenames:	17
Ingredients:	17
NDAs:	20

Drugs and US Patents for Nuvo Pharm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Nuvo Pharms Inc	SODIUM POLYSTYRENE SULFONATE	sodium polystyrene sulfonate	POWDER;ORAL, RECTAL	204071-001	Nov 28, 2014	AA	RX	No	No
Nuvo Pharm	DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE	amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate	TABLET;ORAL	209799-004	Dec 28, 2017	AB	RX	No	No
Nuvo Pharms	PROVIGIL	modafinil	TABLET;ORAL	020717-002	Dec 24, 1998	AB	RX	Yes	Yes
Nuvo Pharms Inc	NAPROXEN	naproxen	TABLET, DELAYED RELEASE;ORAL	091432-002	Sep 19, 2011	AB	RX	No	No
Nuvo Pharms Inc	CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE	chlordiazepoxide hydrochloride; clidinium bromide	CAPSULE;ORAL	211421-001	Jul 7, 2020	AB	RX	No	No

Expired US Patents for Nuvo Pharm

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Nuvo Pharms	PROVIGIL	modafinil	TABLET;ORAL	020717-001	Dec 24, 1998	4,177,290
Nuvo Pharms	PROVIGIL	modafinil	TABLET;ORAL	020717-002	Dec 24, 1998	5,618,845
Nuvo Pharms	PROVIGIL	modafinil	TABLET;ORAL	020717-002	Dec 24, 1998	4,177,290
Nuvo Pharms	PROVIGIL	modafinil	TABLET;ORAL	020717-001	Dec 24, 1998	5,618,845

Paragraph IV (Patent) Challenges for NUVO PHARM drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
	Tablets	100 mg and 200 mg		2009-09-11
	Topical Solution	2.0%		2014-06-03
	Tablets	50 mg, 150 mg and 250 mg		2009-07-24
	Topical Solution	1.5%		2012-07-11

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Nuvo Pharm
• Nuvo Pharms
• Nuvo Pharms Inc